OPSENS REPORTS Q2 2018 RESULTS – CONSOLIDATED PRODUCT SALES UP 44%
12 April 2018Quebec City, Quebec, April 12, 2018 – Opsens Inc. (“Opsens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF) today reported its results for the second quarter ended February 28, 2018. Highlights Consolidated product sales reached $5,352,000 compared with $3,710,000 for the same period last year, an increase of $1,642,000 or 44,3%; Fractional Flow Reserve (“FFR”) revenues reached $3,313,000…
OPSENS ANNOUNCES ELECTION RESULTS FOR THE BOARD OF DIRECTORS AND THE RETIREMENT OF CLAUDE BELLEVILLE
23 January 2018Quebec City, Quebec, January 23, 2018 – Opsens Inc. (“Opsens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF) today held its annual general shareholders’ meeting (the “Meeting”) at its head office in Quebec City, Canada. Opsens’ shareholders re-elected Denis M. Sirois, Denis Harrington, Pat Mackin, Jean Lavigueur, Gaétan Duplain and Louis Laflamme as members of the Board…
OPSENS REPORTS Q1 2018 RESULTS – RECORD QUARTERLY REVENUES WITH GROWTH IN ALL GEOGRAPHIC REGIONS
16 January 2018Quebec City, Quebec, January 15, 2018 – Opsens Inc. (“Opsens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF) today reported its results for the first quarter ended November 30, 2017. Highlights Consolidated revenues reached $6,364,000 for Q1 2018 compared with $3,745,000 for the same period last year, an increase of $2,619,000 or 70%; Fractional Flow Reserve (“FFR”) revenues…
OPSENS’ JAPANESE PARTNER ZEON MEDICAL PROCEEDS WITH CONVERSION OF US$2 MILLION DEBENTURE
27 November 2017Quebec City, Quebec, November 27, 2017 – Opsens Inc. (“Opsens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF) is pleased to announce the conversion of the US$2 million debenture held by Zeon Medical Inc. (“Zeon Medical”), Opsens’ Japanese partner. Zeon Medical has been a client of Opsens since 2004. In 2012, Opsens granted Zeon Medical the exclusive distribution rights for…
OPSENS REPORTS 2017 RESULTS – CONSOLIDATED REVENUES UP 85% FOR FISCAL 2017
15 November 2017OPSENS REPORTS 2017 RESULTS – CONSOLIDATED REVENUES UP 85% FOR FISCAL 2017 Quebec City, Quebec, November 15, 2017 – Opsens Inc. (“Opsens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF) today reported its results for the year ended August 31, 2017. Highlights Record consolidated revenues for fiscal year 2017 at $17.8 million; Revenues for Fractional Flow Reserve (“FFR”)…
OPSENS GETS TECHNOLOGICAL AWARD
24 October 2017Related Article Quebec City, Quebec, October 24, 2017 – Opsens Inc. (“Opsens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF) is proud to announce that its wholly owned subsidiary Opsens Solutions has received the first prize in the category “Best Innovative Product – Physics Measurements” in the Technological Awards Ranking of the magazine Mesures. This honor was bestowed upon…
OPSENS PRESENTS A SHORT FILM AT THE INTERNATIONAL MEDICAL FILM FESTIVAL
19 September 2017OPSENS PRESENTS A SHORT FILM AT THE INTERNATIONAL MEDICAL FILM FESTIVAL Quebec City, Quebec, September 13, 2017 – Opsens Inc. (“Opsens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF) is proud to announce that it has been invited to present a short film as part of International Medical Film Festival – Quebec in Good Health. The film features the OptoWire, Opsens’…
Opsens – Q3 Results
29 June 2017OPSENS REPORTS Q3 2017 RESULTS ANOTHER RECORD QUARTER WITH REVENUES UP 130% TO $4.9 MILLION Quebec City, Quebec, June 29, 2017 – Opsens Inc. (“Opsens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF) today reported its results for the third quarter ended May 31, 2017. Highlights Growth in sales of products to measure Fractional Flow Reserve (“FFR”) in Q3 2017 to…
ROBIN VILLENEUVE APPOINTED AS CHIEF FINANCIAL OFFICER
7 June 2017ROBIN VILLENEUVE APPOINTED AS CHIEF FINANCIAL OFFICER Quebec City, Quebec, June 7, 2017 – Opsens Inc. (“Opsens” or the “Company”) (TSX:OPS)(OTCQX:OPSSF) today announces that to support its growth phase and positioning in the medical market, the Company recruited Robin Villeneuve as Chief Financial Officer. This appointment enters into force immediately. Mr. Villeneuve recently worked as…
OPSENS ANNOUNCES DEPARTURE OF CFO
5 May 2017OPSENS ANNOUNCES DEPARTURE OF CFO Quebec City, Quebec, May 05, 2017 – Opsens Inc. (“Opsens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF) has today announced the departure of Mr. Thierry Dumas, Chief Financial Officer and Corporate Secretary. Mr. Dumas will leave the Company on May 12, 2017. Mr. Louis Laflamme, Opsens’ current President and Chief Executive Officer, will assume…